Display options
Cite
Varró A, Lathrop DA. Sotalol and mexiletine: combination of rate-dependent electrophysiological effects. J Cardiovasc Pharmacol. 1990;16(4):557-67doi: 10.1097/00005344-199010000-00006.
Varró, A., & Lathrop, D. A. (1990). Sotalol and mexiletine: combination of rate-dependent electrophysiological effects. Journal of cardiovascular pharmacology, 16(4), 557-67. https://doi.org/10.1097/00005344-199010000-00006
Varró, A, and Lathrop, D A. "Sotalol and mexiletine: combination of rate-dependent electrophysiological effects." Journal of cardiovascular pharmacology vol. 16,4 (1990): 557-67. doi: https://doi.org/10.1097/00005344-199010000-00006
Varró A, Lathrop DA. Sotalol and mexiletine: combination of rate-dependent electrophysiological effects. J Cardiovasc Pharmacol. 1990 Oct;16(4):557-67. doi: 10.1097/00005344-199010000-00006. PMID: 1706796.
Copy Download .nbib Format: NLM
Share it on

J Cardiovasc Pharmacol. 1990 Oct;16(4):557-67. doi: 10.1097/00005344-199010000-00006.

Sotalol and mexiletine: combination of rate-dependent electrophysiological effects.

Journal of cardiovascular pharmacology

A Varró, D A Lathrop

Affiliations

  1. Department of Pediatrics, University of Cincinnati College of Medicine, Ohio.

PMID: 1706796 DOI: 10.1097/00005344-199010000-00006

Abstract

The rate-dependent electrophysiological effects of sotalol (30 microM), mexiletine (10 and 18 microM), and their coadministration were examined in isolated dog cardiac Purkinje fibers following abrupt changes in pacing cycle length. Combination of 30 microM sotalol with 10 microM mexiletine significantly lengthened premature action potential durations at diastolic intervals of less than 50 ms while the basic action potential duration evoked at a stimulus frequency of 2 Hz was not affected. This effect on the premature action potential duration was attenuated when the higher mexiletine concentration (18 microM) was coadministered with sotalol. The fast time constant for restitution of the action potential duration was significantly slowed by either combination. Coadministration of sotalol and mexiletine, like mexiletine alone, produced a rate-dependent depression of Vmax that displayed a second slow time component during recovery. This slow component for recovery of Vmax was not distinguished in the absence of drug or in the presence of sotalol alone. Sotalol-induced lengthening of the action potential duration observed at slow pacing frequencies was also attenuated by addition of mexiletine; and, under these conditions, Purkinje fiber early afterdepolarizations were prevented. In addition, the range of premature action potential durations was significantly decreased by mexiletine and by the combination, while sotalol alone increased this range slightly. These results indicate that coadministration of sotalol and mexiletine may provide beneficial electrophysiological effects expected to provide enhanced antiarrhythmic efficacy and fewer proarrhythmic complications in patients.

Similar articles

Substances

MeSH terms

Publication Types

Grant support

LinkOut - more resources